AssetMark’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
AssetMark's VIR Position: Q3 2026 in Review
AssetMark opened a new position in Vir Biotechnology (VIR) in Q3 2026: 51 shares worth $570. The stake represents ﹤0.01% of the portfolio and ranks #3371 among its holdings.
202 funds tracked by Wall St. Rank hold VIR as of Q3 2026.
- AssetMark held 51 shares of Vir Biotechnology worth $570 as of Q3 2026.
- Vir Biotechnology was a new AssetMark position in Q3 2026.
- Vir Biotechnology made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3371 holding.
- 202 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.